A detailed history of Voya Investment Management LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 257,531 shares of SMMT stock, worth $4.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
257,531
Previous 257,046 0.19%
Holding current value
$4.6 Million
Previous $2 Million 181.39%
% of portfolio
0.01%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.89 - $31.93 $3,341 - $15,486
485 Added 0.19%
257,531 $5.64 Million
Q2 2024

Dec 03, 2024

SELL
$2.39 - $10.92 $1,159 - $5,296
-485 Reduced 0.19%
257,046 $2 Million
Q2 2024

Aug 14, 2024

BUY
$2.39 - $10.92 $520,016 - $2.38 Million
217,580 Added 551.31%
257,046 $2 Million
Q1 2024

Dec 06, 2024

SELL
$2.55 - $5.07 $556,065 - $1.11 Million
-218,065 Reduced 84.68%
39,466 $163,000
Q1 2024

May 15, 2024

SELL
$2.55 - $5.07 $21,845 - $43,434
-8,567 Reduced 17.84%
39,466 $163,000
Q4 2023

Feb 14, 2024

BUY
$1.67 - $2.83 $2,887 - $4,893
1,729 Added 3.73%
48,033 $125,000
Q2 2023

Aug 14, 2023

BUY
$1.32 - $2.81 $61,121 - $130,114
46,304 New
46,304 $116,000
Q2 2022

Aug 15, 2022

SELL
$0.92 - $2.38 $9,778 - $25,297
-10,629 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.45 - $5.64 $1,215 - $2,797
-496 Reduced 4.46%
10,629 $29,000
Q3 2021

Nov 15, 2021

SELL
$4.83 - $8.27 $8,529 - $14,604
-1,766 Reduced 13.7%
11,125 $56,000
Q2 2021

Aug 16, 2021

BUY
$5.15 - $8.46 $66,388 - $109,057
12,891 New
12,891 $96,000

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.6B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.